Company / Working Capital
Veracyte, Inc. Working Capital History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$428.4M
FY2025
5-year range
$179.0M / $428.4M
FY2021-FY2025
Trend
+45.9%
vs FY2024
Sector context
#74 of 165
Health Care
What the data says
At $428M, Veracyte, Inc.'s working capital ranks #74 of 165 in the Health Care sector. Working Capital has increased for 4 consecutive years, from $179M in FY2021 to $428M in FY2025.
Based on SEC 10-K filings.
$428M in FY2025 with a 5-year CAGR of +3.6%.
Improved from $224M to $428M over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- +32.1%
- 5-Year CAGR
- +3.6%
- 10-Year CAGR
- -
Sector benchmark
#74 of 165 in Health CareTop 45% of 165This company $428.4M Sector average $814.4M
▼
-47.4% below sector average
Key checks
Key Insights
- Veracyte, Inc.'s working capital has grown for 4 consecutive years.
- 5-year CAGR of +3.6%, indicating consistent growth.
- In FY2025, working capital increased 45.9% year-over-year.
- Ranks #74 out of 165 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 6.19 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $428.4M | +45.9% |
| FY2024 | $293.6M | +30.9% |
| FY2023 | $224.4M | +20.6% |
| FY2022 | $186.0M | +4.0% |
| FY2021 | $179.0M | -50.1% |
| FY2020 | $358.9M | +110.8% |
| FY2019 | $170.2M | +102.9% |
| FY2018 | $83.9M | +100.2% |
| FY2017 | $41.9M | -32.5% |
| FY2016 | $62.1M | +87.1% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026